Ablaze Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy
31 Mar 2023 //
PR NEWSWIRE
Ablaze and Yonghe Pharma initiate development and manufacturing agreement
27 Dec 2022 //
INDIANPHARMAPOST
Ablaze Pharma & Yonghe Pharma Initiate Development and Mfg Services Agreement
27 Dec 2022 //
PRNEWSWIRE
Ablaze Pharma and Wenjiang District Gov. of Chengdu Sign Agreement
08 Aug 2022 //
CONTRACTPHARMA
Ablaze Pharma Aligned Strategic Agreement With Wenjiang District Govt of Chengdu
02 Aug 2022 //
PRNEWSWIRE